Copyright Reports & Markets. All rights reserved.

Global Histone Deacetylase 1 Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Histone Deacetylase 1 Market Overview

      • 1.1 Product Overview and Scope of Histone Deacetylase 1
      • 1.2 Histone Deacetylase 1 Segment by Type
        • 1.2.1 Global Histone Deacetylase 1 Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 RCY-1305
        • 1.2.3 HG-3001
        • 1.2.4 CS-3158
        • 1.2.5 ACY-957
        • 1.2.6 ST-3595
        • 1.2.7 Others
      • 1.3 Histone Deacetylase 1 Segment by Application
        • 1.3.1 Histone Deacetylase 1 Consumption Comparison by Application (2014-2025)
        • 1.3.2 Alopecia
        • 1.3.3 Endometrial Cancer
        • 1.3.4 Myelofibrosis
        • 1.3.5 Neurology
        • 1.3.6 Skin Cancer
        • 1.3.7 Others
      • 1.3 Global Histone Deacetylase 1 Market by Region
        • 1.3.1 Global Histone Deacetylase 1 Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Histone Deacetylase 1 Market Size
        • 1.4.1 Global Histone Deacetylase 1 Revenue (2014-2025)
        • 1.4.2 Global Histone Deacetylase 1 Production (2014-2025)

      2 Global Histone Deacetylase 1 Market Competition by Manufacturers

      • 2.1 Global Histone Deacetylase 1 Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Histone Deacetylase 1 Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Histone Deacetylase 1 Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Histone Deacetylase 1 Production Sites, Area Served, Product Types
      • 2.5 Histone Deacetylase 1 Market Competitive Situation and Trends
        • 2.5.1 Histone Deacetylase 1 Market Concentration Rate
        • 2.5.2 Histone Deacetylase 1 Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Histone Deacetylase 1 Production Market Share by Regions

      • 3.1 Global Histone Deacetylase 1 Production Market Share by Regions
      • 3.2 Global Histone Deacetylase 1 Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Histone Deacetylase 1 Production
        • 3.4.1 North America Histone Deacetylase 1 Production Growth Rate (2014-2019)
        • 3.4.2 North America Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Histone Deacetylase 1 Production
        • 3.5.1 Europe Histone Deacetylase 1 Production Growth Rate (2014-2019)
        • 3.5.2 Europe Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Histone Deacetylase 1 Production (2014-2019)
        • 3.6.1 China Histone Deacetylase 1 Production Growth Rate (2014-2019)
        • 3.6.2 China Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Histone Deacetylase 1 Production (2014-2019)
        • 3.7.1 Japan Histone Deacetylase 1 Production Growth Rate (2014-2019)
        • 3.7.2 Japan Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Histone Deacetylase 1 Consumption by Regions

      • 4.1 Global Histone Deacetylase 1 Consumption by Regions
      • 4.2 North America Histone Deacetylase 1 Consumption (2014-2019)
      • 4.3 Europe Histone Deacetylase 1 Consumption (2014-2019)
      • 4.4 China Histone Deacetylase 1 Consumption (2014-2019)
      • 4.5 Japan Histone Deacetylase 1 Consumption (2014-2019)

      5 Global Histone Deacetylase 1 Production, Revenue, Price Trend by Type

      • 5.1 Global Histone Deacetylase 1 Production Market Share by Type (2014-2019)
      • 5.2 Global Histone Deacetylase 1 Revenue Market Share by Type (2014-2019)
      • 5.3 Global Histone Deacetylase 1 Price by Type (2014-2019)
      • 5.4 Global Histone Deacetylase 1 Production Growth by Type (2014-2019)

      6 Global Histone Deacetylase 1 Market Analysis by Applications

      • 6.1 Global Histone Deacetylase 1 Consumption Market Share by Application (2014-2019)
      • 6.2 Global Histone Deacetylase 1 Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Histone Deacetylase 1 Business

      • 7.1 4SC AG
        • 7.1.1 4SC AG Histone Deacetylase 1 Production Sites and Area Served
        • 7.1.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.1.3 4SC AG Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Acetylon Pharmaceuticals, Inc.
        • 7.2.1 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Production Sites and Area Served
        • 7.2.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Chipscreen Biosciences Ltd
        • 7.3.1 Chipscreen Biosciences Ltd Histone Deacetylase 1 Production Sites and Area Served
        • 7.3.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Curis, Inc.
        • 7.4.1 Curis, Inc. Histone Deacetylase 1 Production Sites and Area Served
        • 7.4.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.4.3 Curis, Inc. Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 GlaxoSmithKline Plc
        • 7.5.1 GlaxoSmithKline Plc Histone Deacetylase 1 Production Sites and Area Served
        • 7.5.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.5.3 GlaxoSmithKline Plc Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 HitGen LTD
        • 7.6.1 HitGen LTD Histone Deacetylase 1 Production Sites and Area Served
        • 7.6.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.6.3 HitGen LTD Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 IRBM Science Park SpA
        • 7.7.1 IRBM Science Park SpA Histone Deacetylase 1 Production Sites and Area Served
        • 7.7.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.7.3 IRBM Science Park SpA Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Italfarmaco S.p.A.
        • 7.8.1 Italfarmaco S.p.A. Histone Deacetylase 1 Production Sites and Area Served
        • 7.8.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.8.3 Italfarmaco S.p.A. Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 MEI Pharma, Inc.
        • 7.9.1 MEI Pharma, Inc. Histone Deacetylase 1 Production Sites and Area Served
        • 7.9.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.9.3 MEI Pharma, Inc. Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Merck & Co., Inc.
        • 7.10.1 Merck & Co., Inc. Histone Deacetylase 1 Production Sites and Area Served
        • 7.10.2 Histone Deacetylase 1 Product Introduction, Application and Specification
        • 7.10.3 Merck & Co., Inc. Histone Deacetylase 1 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Mirati Therapeutics Inc.
      • 7.12 Oncolys BioPharma Inc.
      • 7.13 Sigma-Tau S.p.A.
      • 7.14 Syndax Pharmaceuticals, Inc.
      • 7.15 TetraLogic Pharmaceuticals

      8 Histone Deacetylase 1 Manufacturing Cost Analysis

      • 8.1 Histone Deacetylase 1 Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Histone Deacetylase 1
      • 8.4 Histone Deacetylase 1 Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Histone Deacetylase 1 Distributors List
      • 9.3 Histone Deacetylase 1 Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Histone Deacetylase 1 Market Forecast

      • 11.1 Global Histone Deacetylase 1 Production, Revenue Forecast
        • 11.1.1 Global Histone Deacetylase 1 Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Histone Deacetylase 1 Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Histone Deacetylase 1 Price and Trend Forecast (2019-2025)
      • 11.2 Global Histone Deacetylase 1 Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Histone Deacetylase 1 Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Histone Deacetylase 1 Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Histone Deacetylase 1 Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Histone Deacetylase 1 Production, Revenue Forecast (2019-2025)
      • 11.3 Global Histone Deacetylase 1 Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Histone Deacetylase 1 Consumption Forecast (2019-2025)
        • 11.3.2 Europe Histone Deacetylase 1 Consumption Forecast (2019-2025)
        • 11.3.3 China Histone Deacetylase 1 Consumption Forecast (2019-2025)
        • 11.3.4 Japan Histone Deacetylase 1 Consumption Forecast (2019-2025)
      • 11.4 Global Histone Deacetylase 1 Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Histone Deacetylase 1 Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Histone Deacetylase 1 market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Histone Deacetylase 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase 1 market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        4SC AG
        Acetylon Pharmaceuticals, Inc.
        Chipscreen Biosciences Ltd
        Curis, Inc.
        GlaxoSmithKline Plc
        HitGen LTD
        IRBM Science Park SpA
        Italfarmaco S.p.A.
        MEI Pharma, Inc.
        Merck & Co., Inc.
        Mirati Therapeutics Inc.
        Oncolys BioPharma Inc.
        Sigma-Tau S.p.A.
        Syndax Pharmaceuticals, Inc.
        TetraLogic Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        RCY-1305
        HG-3001
        CS-3158
        ACY-957
        ST-3595
        Others

        Segment by Application
        Alopecia
        Endometrial Cancer
        Myelofibrosis
        Neurology
        Skin Cancer
        Others

        Buy now